Cochrane | Trusted evidence. Informed decisions. Better health.
Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health.
Duloxetine for treating painful neuropathy, chronic pain or
We identified 18 trials, which included 6407 participants. We found 12 of these studies in the literature search for this update. Eight studies included a total of 2728 participants with painful …
Oral painkillers available without prescription for acute pain
We identified OTC analgesics available in the UK, Australia, Canada, and the USA by examining online pharmacy websites. We also included some analgesics (diclofenac potassium, …
How accurate are the Addenbrooke's Cognitive Examination III
There is insufficient information in terms of both quality and quantity to recommend the use of either the ACE-III or mini-ACE for the screening of dementia or MCI in patients presenting …
Our evidence - Cochrane
Cochrane works collaboratively with contributors around the world to produce authoritative, relevant, and reliable evidence, in the form of Cochrane Reviews.
What are the benefits and risks of vaccines for preventing COVID …
Dec 7, 2022 · Key messages – Most vaccines reduce, or probably reduce, the number of people who get COVID-19 disease and severe COVID-19 disease. – Many vaccines likely increase …
How accurate are rapid antigen tests for diagnosing COVID-19?
Accurate rapid diagnostic tests for SARS-CoV-2 infection would be a useful tool to help manage the COVID-19 pandemic. Testing strategies that use rapid antigen tests to detect current …
Bupropion for attention deficit hyperactivity disorder (ADHD
The findings of this review, which compared bupropion to placebo for adult ADHD, indicate a possible benefit of bupropion. We found low-quality evidence that bupropion decreased the …
About us - Cochrane
Cochrane is an international network with headquarters in the UK, a registered not-for-profit organization, and a member of the UK National Council for Voluntary Organizations.Cochrane …
Donepezil for people with dementia due to Alzheimer's disease
There is moderate-quality evidence that people with mild, moderate or severe dementia due to Alzheimer's disease treated for periods of 12 or 24 weeks with donepezil experience small …